These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27090973)

  • 1. Will Changes to Prostate Cancer Screening Guidelines Preserve Benefits and Reduce Harm?
    Loeb S
    Eur Urol; 2017 Jan; 71(1):66-67. PubMed ID: 27090973
    [No Abstract]   [Full Text] [Related]  

  • 2. Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?
    Roobol MJ
    Eur Urol; 2015 Sep; 68(3):363-4. PubMed ID: 25769985
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA in screening for prostate cancer: more good than harm or more harm than good?
    Duffy MJ
    Adv Clin Chem; 2014; 66():1-23. PubMed ID: 25344984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Vickers A
    Eur Urol; 2013 Oct; 64(4):682-3. PubMed ID: 23998500
    [No Abstract]   [Full Text] [Related]  

  • 6. Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.
    ;
    Int J Urol; 2010 Oct; 17(10):830-8. PubMed ID: 20825509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening: Do guidelines matter?
    Kearns JT; Gore JL
    Cancer; 2016 Dec; 122(24):3760-3761. PubMed ID: 27656862
    [No Abstract]   [Full Text] [Related]  

  • 8. Interpreting the Statistics on Potential Benefits of Prostate Cancer Screening.
    Jones K
    Am Fam Physician; 2017 Apr; 95(7):412-413. PubMed ID: 28409604
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms.
    Vickers AJ
    Ann Intern Med; 2017 Oct; 167(7):509-510. PubMed ID: 28869975
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Consensus of prostate cancer screening].
    Prostate Cancer Working Group of Genitourinary Cancer Committee in Chinese Anti-Cancer Association
    Zhonghua Wai Ke Za Zhi; 2017 May; 55(5):340-342. PubMed ID: 28464572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence that prostate-specific antigen screening reduces prostate cancer mortality.
    Stampfer MJ; Jahn JL; Gann PH
    J Natl Cancer Inst; 2014 Mar; 106(3):dju026. PubMed ID: 24610908
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.
    Carter HB
    JAMA; 2018 May; 319(18):1866-1868. PubMed ID: 29800999
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for prostate cancer: an updated review.
    Marta GN; Hanna SA; Fernandes da Silva JL; Carvalho Hde A
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):101-8. PubMed ID: 23259431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening.
    Loeb S
    J Clin Oncol; 2016 Aug; 34(23):2684-6. PubMed ID: 27325846
    [No Abstract]   [Full Text] [Related]  

  • 16. Discuss prostate cancer screening with your doctor.
    The Lancet
    Lancet; 2017 Apr; 389(10079):1582. PubMed ID: 28443541
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Taneja SS
    J Urol; 2016 Feb; 195(2):350-1. PubMed ID: 26852972
    [No Abstract]   [Full Text] [Related]  

  • 18. Guideline of guidelines: prostate cancer screening.
    Loeb S
    BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"?
    Barry MJ; Albertsen PC
    Ann Intern Med; 2016 May; 164(10):687-8. PubMed ID: 26902323
    [No Abstract]   [Full Text] [Related]  

  • 20. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.